Pfizer Whistleblower Exposes Compromised Vaccine Trial Data

A regional director for Pfizer employed at the Ventavia Research Group tells BMJ that Pfizer falsified vaccine data, unblinded patients, and hired inadequately trained vaccine administrators.

Pfizer was also said to be slow following up on adverse reactions from the vaccine.

After notifying the research group of these problems repeatedly Brook Jackson, regional director, notified the FDA in an email.

Ventavia fired her that day.

In an email to the FDA sent September 25th, Jackson said that Ventavia enrolled more than 1000 participants at three sites. The full trial registered 44,000 participants across 153 sights.

Here were some of the complaints she listed:

Participants placed in a hallway after injection and not being monitored by clinical staff

Lack of timely follow-up of patients who experienced adverse events

Protocol deviations not being reported

Vaccines not being stored at proper temperatures

Mislabelled laboratory specimens, and

Targeting of Ventavia staff for reporting these types of problems.

Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial

Other anonymous employees reported similar complaints as Jackson.

Related: How To Detoxify and Heal From Vaccinations – For Adults and Children